141 related articles for article (PubMed ID: 37898413)
1. Biallelic mutations in the CFHR genes underlying atypical hemolytic uremic syndrome in a patient with catastrophic adult-onset Still's disease and recurrent macrophage activation syndrome: A case report.
Dillemans L; Bekhuis Y; Betrains A; Yu K; van Hemelen M; Pörtner N; De Somer L; Matthys P; Breckpot J; Tousseyn T; Peetermans M; Proost P; Wouters C; Vanderschueren S
Clin Immunol; 2023 Dec; 257():109815. PubMed ID: 37898413
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
3. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
4. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
6. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature.
Suda T; Zoshima T; Takeji A; Suzuki Y; Mizushima I; Yamada K; Nakashima A; Yachie A; Kawano M
Intern Med; 2020 Mar; 59(5):721-728. PubMed ID: 31708548
[TBL] [Abstract][Full Text] [Related]
7. Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
Wang R; Li T; Ye S; Lv L; Chen S; Wang X; Bao CD; Fu Q
Clin Rheumatol; 2022 Sep; 41(9):2817-2823. PubMed ID: 35590113
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome with lung involvement complicating adult-onset Still's disease.
Wang CR; Tsai YS; Ma IC
Neth J Med; 2018 Dec; 76(10):442-444. PubMed ID: 30569890
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
[TBL] [Abstract][Full Text] [Related]
10. Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome.
Gianella S; Schaer DJ; Schwarz U; Kurrer M; Heppner FL; Fehr J; Seebach JD
Am J Hematol; 2008 May; 83(5):424-7. PubMed ID: 18183612
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset Still's disease with concurrent thrombotic microangiopathy: Observations from pooled analysis for an uncommon finding.
Ananthaneni A; Shimkus G; Weis F; Adu-Dapaah E; Lakra R; Ramadas P; Hayat S
Eur J Haematol; 2024 Apr; 112(4):484-492. PubMed ID: 37997494
[TBL] [Abstract][Full Text] [Related]
12. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis.
Félix FH; Leal LK; Fontenele JB
Rheumatol Int; 2009 Jun; 29(8):973-4. PubMed ID: 19115058
[TBL] [Abstract][Full Text] [Related]
13. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
14. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
[TBL] [Abstract][Full Text] [Related]
17. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
Gulzar M; Sabir A; Hamdani MA; Saadia A
J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
[TBL] [Abstract][Full Text] [Related]
20. Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
Horiuchi Y; Hashimoto K; Horikoshi H; Sano A; Kawamura Y; Fujita N; Kimata M; Ono Y; Obuchi Y; Makino A; Kaneko M; Kimura F; Itoh K; Tanaka Y
Medicine (Baltimore); 2022 Jul; 101(28):e29354. PubMed ID: 35839054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
